Background: RNA interference (RNAi) is a cellular pathway of gene silencing in a sequence-specific manner at the messenger RNA level. The basic mechanism behind RNAi is the breaking of a double-stranded RNA (dsRNA) matching a specific gene sequence into short pieces called short interfering RNA, which trigger the degradation of mRNA that matches its sequence. In this study, we explored the effects of RNAi in reducing the target gene expression in human myeloid leukemia cell lines. Methods: Four myeloid leukemia cell lines (HL-60, U937, THP-1, and K562) were transfected with dsRNA duplexes corresponding to the endogenous c-raf and bcl-2 genes and the gene expression inhibition was assessed. The effect of RNAi on cell differentiation was studied; the apoptosis induction and the sensitization of the leukemia cell lines to etoposide and daunorubicin were quantified by flowcytometric methods. Results: Transfection of the myeloid leukemia cell lines with dsRNA corresponding to c-raf and bcl-2 genes decreased the expression of Raf-1 and Bcl-2 proteins. RNAi for c-raf gene blocked the appearance of the monocytic differentiation induced by treatment with TPA. Combined RNAi for c-raf and bcl-2 induced apoptosis in HL-60, U937, and THP-1 cells and increased chemosensitivity to etoposide and daunorubicin. Conclusions: RNAi is a functional pathway in human myeloid leukemia cell lines and combined RNAi of c-raf and bcl-2 genes may represent a novel approach to leukemia, providing a means to overcome the resistance to chemotherapeutic agents and ultimately to augment the efficacy of chemotherapy in myeloid leukemia.
R
NA interference (RNAi) is a cellular pathway that was first discovered in the nematode worm Caenorhabditis elegans,
1 but is present in many other organisms like the fruitfly Drosophila, 2 -4 insects, 5 protozoa, 6 planaria, 7 and hydra 8 and seems to represent an ancient pathway. 9 This phenomenon was given a variety of names like cosuppression, quelling, gene silencing, and RNAi, as various research groups had been seeing clues that cells have some novel way of shutting down or ''silencing'' genes. 10 RNAi seems to be a critical pathway that cells use to protect themselves against viruses and certain kinds of genetic damage, and possibly to control gene expression as well. RNAi is apparently triggered when the cell senses some kind of danger to the integrity of the genome represented by an invading virus or the mobilization of the bits of repetitive DNA called transposons, which can jump in the genome -causing mutations if they happen to interact with a gene, or possibly the production of an abnormal messenger RNA. 10 The basic mechanism of RNAi is that a double -stranded RNA (dsRNA ) is broken into short pieces called short interfering RNA ( siRNA ), which trigger the activation of an RNA -cutting enzyme (ribonuclease ) directed specifically to degrade just the messenger RNA related to the trigger by an identical sequence, whereas other genes remain unaffected. The RNAi pathway comprises at least four sequential steps: ATP -dependent dsRNA processing, ATP -independent incorporation of siRNA into an inactive $360 -kDA complex, ATP -dependent unwinding of the siRNA duplex, and ATPindependent recognition and cleavage of the target RNA. 11 Each siRNA duplex cleaves the target RNA at a single site, with two-or three -nucleotide overhanging 3 0 ends within the siRNA duplex being required for efficient target cleavage. 12 RNAi was difficult to observe in mammalian cells because dsRNA of any sequence triggers a global shutdown of protein synthesis 13 and masks any sequence-specific effects that might occur from the RNAi pathway. 14 The nonspecific effects occur because dsRNA activates two enzymes: ( a) the dsRNA -activated protein kinase PKR, which, in its active form, phosphorylates the translation factor eIF2a to shut down all protein synthesis; and (b ) 2 0 ,5 0 -oligoadenylate synthetase, which synthesizes a molecule that activates RNaseL, a nonspecific enzyme that targets all messenger RNA.
14 However, this nonspecific pathway requires dsRNA longer than 30 bp and will not occur for shorter dsRNA. 13 -15 Therefore, because of this size discrimination, siRNA are able to bypass the nonspecific response in mammalian cells, and reproducible, sequence-specific siRNA inhibition of various luciferase transgenes in NIH /3T3, COS -7, HeLa, and 293 cell lines was observed. 16 In this study, we used four myeloid leukemia cell lines ( HL -60, U937, THP -1, and K562 ) in order to explore the potency of RNAi using siRNA duplexes corresponding to the endogenous c-raf and bcl -2 genes. We chose, as targets of RNAi, two proteins demonstrated as factors of chemoresistance in myeloid leukemia: the Raf -1 kinase and the Bcl -2 oncoprotein, 17 -19 which were described as interacting in suppression of the programmed cell death, 20 with Raf -1 being also incriminated as a control factor of the in vitro proliferation rate of acute myeloblastic leukemia cells. 21 With the exception of K562 cell line, which express only Raf -1, all the other cell lines express both Raf -1 and Bcl -2 proteins at high levels. Our results demonstrate that RNAi is a functional pathway in myeloid leukemia cell lines and suggest the potential utility of the RNAi phenomenon as a novel therapeutic approach to myeloid leukemia.
Materials and methods

Leukemic cell lines
The HL -60 human promyelocytic acute leukemia cell line 22 was purchased from the American Type Culture Collection ( Rockville, MD ). The U937 promonocytic /histocytic acute leukemia cell line, 23 THP -1 mature monocytic acute leukemia cell line, 24 and K562 chronic myelogenous in erythroblastic blast crisis cell line 25 were purchased from the Health Science Research Resources Bank (Osaka, Japan ).
Cell culture and differentiation
All cells were cultured in RPMI 1640 medium (Nikken BioMedical Laboratory, Kyoto, Japan ) supplemented with 10% fetal bovine serum ( Life Technologies, Grand Island, NY ), 2 mM L -glutamine, and 1% antibiotics ( 100 IU / mL penicillin, 100 g /mL streptomycin, and fungizone; BioWhittaker, Walkersville, MA ) in six -well plates ( BD Labware, Franklin Lakes, NJ ), with an initial concentration of 2Â10 5 cells /mL. The cells were placed in a 5% CO 2 -95% air fully humidified atmosphere at 378C and incubated until harvesting. The HL -60 cells differentiation along the monocytic series was induced by a 3-day incubation with 1 ng /mL 12-O -tetradecanoylphorbol 13 -acetate ( TPA ) from Sigma Aldrich ( Steinheim, Germany ).
siRNA and phosphorothioate antisense DNA siRNA corresponding to the c -raf and bcl -2 genes were designed according to the report of Elbashir et al. 16 The sequences of 21 -nucleotide (nt ) sense ( S ) and antisense ( AS ) RNA with a 2 -nt overhang composed of TT ( DNA ) were as follows: S, 5 0 -UAG UUC AGC AGC AGU UUG GCU ATT-3 0 and AS, 5 0 -UAG CCA AAC UGC UGA ACU ATT-3 0 for the c -raf gene ( nt 224 -244 and 222-242; GenBank X03484 ); S, 5 0 -GUA CAU CCA UUA UAA GCU GTT-3 0 and AS, 5 0 -CAG CUU AUA AUG GAU GUA CTT-3 0 for the bcl -2 gene (nt 197 -217 and 195-215; M13995 ). SiRNA corresponding to the luciferase gene used as a control in the present study was identical with the one described in Ref. [16 ] : S, 5
0 -CUU ACG CUG AGU ACU UCG ATT-3 0 and AS, 5 0 -UCG AAG UAC UCA GCG UAA GTT-3 0 . For annealing to form RNA duplexes, 100 M of each S and AS RNA was incubated for 30 seconds at 908C in RNase -free distilled water followed by a 30-minute incubation at room temperature. The phosphorothioate antisense oligodeoxynucleotides ( AS -PS ODNs) corresponding to the c -raf and bcl -2 genes were identical with those from the reports of Monia et al 26 and Konopleva et al, 27 5 0 -TCC CGC CTG TGA CAT GCA TT-3 0 ( nt 2484 -2503; X03484) and 5 0 -CAG CGT GCG CCA TCC TTC CC -3 0 (nt 140 -159; M13995), respectively. S and AS RNA and PS -AS ODNs were synthesized and purified by Japan BioService (Saitama, Japan ). The cell transfection was performed with the Oligofectamine Reagent (Invitrogen Life Technologies, Carlsbad, CA ) according to the optimized procedure recommended by the producer.
Cellular surface and intracytoplasmic flowcytometric analysis
For the surface immunofluorescence analysis, cells were extracted from their culture media at the appropriate times, washed twice in PBS, and 10 6 cells were stained at 48C for 30 minutes with 20 l of RPE -conjugated mouse antihuman CD14 monoclonal antibody (clone TUK4, IgG 2a ; Dako, Glostrup, Denmark ), or a corresponding fluorescent -labeled murine isotype -matched control antibody for the background staining ( Becton Dickinson Immunocytometry Systems, San Jose, CA ). The cells were then washed again in PBS and subjected to flowcytometric analysis for red fluorescence (FL2 detector) on a FACScan (Becton Dickinson, Mountain View, CA ) equipped with a 488 -nM blue argon laser. Ten thousand events were recorded each time, and results were plotted on logarithmic scales. The percentages of cells expressing the antigen on their surface were calculated using the Cell Quest software ( Becton Dickinson ).
In order to determine the relative levels of intracellular Raf -1 and Bcl -2 proteins, the cells were fixed and permeabilized using the two -step IntraStain from Dako, according to the procedure recommended by the manufacturer. Following permeabilization, the cells were washed and incubated for 20 minutes at 48C with the mouse anti -Raf -1 monoclonal antibody (clone 53, IgG 1 ; Transduction Laboratories, Lexington, KY ), with the FITC -conjugated mouse anti-Bcl -2 monoclonal antibody ( clone 124, IgG 1 ; Dako ), or with an isotype -matched mouse immunoglobulin (FITCconjugated in the case of Bcl -2, nonconjugated for Raf -1, clone MOPC-31C, IgG 1 ; Becton Dickinson ) for the control samples. For Raf -1, the cells were then washed again and incubated with an FITC -labeled rat antimouse antibody ( clone A85 -1, IgG 1 ; Becton Dickinson) for another 20 minutes at 48C. Finally, the cells were washed thrice and subjected to flowcytometric analysis. Debris were excluded from analysis by a threshold imposed using the forward scatter /side scatter criteria. Ten thousand events were analyzed each time for the FITC green fluorescence ( measured by the FL1 detector at 530 nm ), and the mean fluorescence intensity (MFI ) of the electronically amplified signal was calculated for the logarithmic scale histograms using the Cell Quest software.
Immunoblotting
After extraction from the culture medium and washing with PBS, the cells were homogenized using an ultrasonic cell breaker (Powersonic model 50; Yamato Kagaku, Tokyo, Japan ), then lysed in cell lysis buffer. Extracts equivalent to 50 g of total protein were separated by SDS polyacrylamide gel electrophoresis, then electroblotted at 15 V for 35 minutes to supported nitrocellulose membranes ( GIBCO BRL, Gaithersburg, MD ) with a plate electrode apparatus ( Idea Scientific, Minneapolis, MN ). The filters were blocked with 5% nonfat dried milk in Tris -buffered saline with Tween -20 (TBST ) for 60 minutes, followed by incubation with each antibody at 48C overnight, and then incubated for 1 hour at room temperature with 1:1000 horseradish peroxidase -conjugated rabbit antimouse Ig ( Amersham, Arlington Heights, IL ) in 2% nonfat dried milk in TBST. The bound antibody was detected with an enhanced chemiluminescence system ( ECL kit; Amersham Pharmacia Biotech, Buckinghamshire, UK ) and exposed to X -ray films. To verify that equal amounts of total proteins were present in all lanes, b -actin staining served as internal standard for all filters. The experiments were repeated twice.
Morphologic and cytochemical assessment of cells
Cytospin slides were prepared by centrifugation at 150Âg for 5 minutes using Cytospin 3 ( Shandon, Pittsburgh, PA ) and stained with Wright and Giemsa solutions ( Merck, Darmstadt, Germany ). Cell morphology and adherence were observed under an Olympus microscope at Â400 magnification.
The cytochemical assessment of nonspecific esterase was done by incubating the cells for 45 minutes at room temperature with a mixture of a-naphtyl acetate and hexazotized para -rosanilin, washing and counterstaining with 1% methyl green for 1 minute, followed by the microscopical observation of the dark red intracytoplasmic granules. The cell counting was made on an improved Neubauer hemocytometric chamber ( Erma, Tokyo, Japan ).
Programmed cell death assays
The Annexin V fluorescent assay was performed by extracting the cells from the culture media, washing twice with PBS, and staining 10 6 cells with 2 l of Annexin VFluos FITC -labeled ( Boehringer Mannheim, Mannheim, Germany ) in the incubation buffer ( 10 mM Hepes /NaOH, pH 7.4, 140 mM NaCl, 5 mM CaCl 2 ) for 20 minutes at room temperature in the dark. In order to discriminate between early apoptotic cells and cells that have permeabilized their membranes (late apoptotic cells, or secondary necrotic ), a counterstain with 2 g /mL 7-amino -actinomycin D ( 7-AAD; Molecular Probes, Eugene, OR ) was performed.
The caspase -3 fluorescent assay was performed according to the manufacturer's instructions. Cells were washed and permeabilized with the two -step IntraStain, washed again, and 10 6 cells were stained for 20 minutes at 48C with 20 l of the PE -conjugated antiactive caspase-3 antibody (PharMingen, Tokyo, Japan ), which recognizes active human caspase -3, as opposed to procaspase -3. The following flowcytometric analysis could discriminate the cells that have or have not exposed the conformational epitope formed by the cleavage of the procaspase -3.
Poly (ADP -ribose ) polymerase (PARP ) is a 116 -kDa nuclear protein, which plays a role in DNA repair and is strongly activated by DNA strand breaks, being cleaved during apoptosis by caspase -3 and caspase -7 and yielding an 85-and 25-kDa fragment, respectively -this cleavage being considered one of the classical characteristics of apoptosis. 28 The anti -PARP cleavage site (214 /215 ) antibody from BioSource International (Camarillo, CA ) specifically recognizes the 85-kDa fragment of cleaved PARP. Cells were fixed and permeabilized with Dako IntraStain, washed and stained with 10 l of FITC -conjugated anti -PARP antibody for 30 minutes at 48C, washed again, and analyzed by flowcytometry.
The 3,3 0 -dihexyloxacarbocyanine iodide (DiOC ) is a mitochondrial transmembrane potentiometric fluorescent marker and its fluorescence decrease reveals the disruption of the mitochondrial transmembrane potential ÁÉ m , an early and irreversible step of ongoing apoptosis. 29 The DiOC assay was performed by incubating 10 6 cells with 40 nM DiOC (Molecular Probes ) in PBS for 20 minutes at 378C, followed by flowcytometric analysis. In this assay, the apoptotic cells were identified by their decreased ÁÉ m ( DiOC low ). The terminal deoxynucleotidyl transferase (TdT )-mediated dUTP nick -end labeling method ( TUNEL method) was used to detect chromatin DNA fragmentation at the linker DNA site between nucleosomes, giving rise to nuclear DNA fragments consisting of nucleosome multimers. In the TUNEL method, the 3 0 -hydroxyl DNA ends generated by apoptotic endonuclease activity are nick -end -labeled with FITC -dUTP and catalyzed by the TdT enzyme, which causes template -independent addition of nucleotides onto any deoxynucleotide molecule of more than three residues. We performed the TUNEL assay using the Mebstain Apoptosis Kit Direct ( Beckman Coulter, Marseille, France), according to the producer's recommendations.
Statistical analysis
All experiments were performed in triplicate or quadruplicate. The paired Student's t test was used as appropriate to determine the statistical significance of the data obtained. The software used was StatView (Abacus Concepts, Berkeley, CA ). A P value of < .05 was taken to represent a statistically significant difference between group means. The Kolmogorov -Smirnov statistics were used to assess the flowcytometric histograms and the significance of their shifting.
Results
RNAi is more effective than antisense oligodeoxynucleotides in decreasing the expression of c -raf and bcl -2 genes
The effects of RNAi in the acute myeloid leukemia cells studied were assayed by quantifying the endogenous levels of Raf -1 and Bcl -2 proteins, as products of the c -raf and bcl -2 genes, respectively. The efficacy of decreasing the gene expression by siRNA duplexes was compared with that of the PS -AS ODNs. As quantified by the flowcytometric method used, both siRNA duplexes significantly decreased the MFIs of the Raf -1 and Bcl -2 proteins ( MFI 68.5 ± 5.9 in control vs 24.1 ± 4.4 for Raf -1, P <.05; 126.7 ± 9.2 in control vs 44.8± 6.8 for Bcl -2, P < .05 ). As shown in Figure 1, A ( Fig 1B ) .
The MFIs of both Raf -1 FITC and Bcl -2 FITC proteins in the case of siRNA -transfected HL -60 cells were lower than the MFIs in the PS -AS ODN transfected HL -60 cells ( MFI 24.1 ± 4.4 siRNA vs 32.7± 5.2 PS -AS ODN for Raf -1, P < .05; 44.8± 6.8 siRNA vs 58.8 ± 7.1 PS -AS ODN for Bcl -2, P < .05).
RNAi for c -raf is sufficient to block the monocytic differentiation induced by TPA in HL -60 line cells
As c -raf is activated during TPA -induced differentiation of HL -60 cells along the monocytic series, 30 we next investigated if RNAi for c -raf is a phenomenon with enough impact to block the differentiation process induced by TPA. In control samples, treatment of HL -60 cells with 1 ng/ mL TPA for 3 days induced a differentiated phenotype characterized by adherence, increases in a -naphtyl acetate esterase staining, shifting of the nuclear/ cytoplasmic ratio from >1 to <1, and expression of the monocytic surface marker CD14.
As shown in Figure 2 , TPA induced the majority of HL -60 cells to express surface CD14 after 3 days of incubation, whereas transfection with siRNA duplexes for c -raf by itself did not induce surface CD14, but was able to block the appearance of this monocytic marker on the surface of HL -60 cells treated with TPA. This effect was specific for c -raf because neither siRNA duplexes for the luciferase transgene, nor siRNA duplexes for bcl -2 gene did influence the surface CD14 appearance on HL -60 cells treated with TPA. RNAi for c-raf was also able to block the significant increases in a -naphtyl esterase ( nonspecific esterase ) staining, the significant adherence to plastic, and the shifting of the nuclear/ cytoplasmic ratio ( data not shown ), demonstrating that (a ) c-raf expression is essential in the process of monocytic differentiation induced by TPA, and that (b ) RNAi for c -raf is a phenomenon with enough potency to block the differentiation along the monocytic series induced by TPA.
Combined RNAi for c -raf and bcl -2 induces programmed cell death in HL -60, U937, and THP -1 cell lines Following the findings that transfection with siRNA duplexes for c -raf and bcl -2 genes significantly decreased the endogenous levels of Raf -1 and Bcl -2 proteins, we next checked if the RNAi observed affected cell viability by Cancer Gene Therapy RNA interference in myeloid leukemia DP Cioca et al induction of programmed cell death. Using the fluorescent Annexin V assay as a sensitive method to detect the early apoptosis induction, we tested four human myeloid leukemia cell lines, namely the promyelocytic leukemia HL -60 cell line, the acute promonocytic /histocytic leukemia U937 cell line, the acute mature monocytic leukemia THP -1 cell line, and the chronic myelogenous leukemia in erythroblastic blast crisis K562 cell line. As shown in Figure 3 , transfection with up to 800 nM siRNA duplexes for c-raf did not induce programmed cell death in any of the cell lines studied. Transfection with 800 nM siRNA duplexes for bcl -2 gene induced a minimal apoptotic response in HL -60, U937, and THP -1 cell lines, which expressed high Bcl -2 levels, but not in the K562 cell line, which is Bcl -2-negative. 31, 32 However, a significant induction of programmed cell death (P < .05) was observed after the combined transfection with 400 nM siRNA duplexes for c -raf and 400 nM siRNA duplexes for bcl -2 gene in HL -60, U937, and THP -1 cell lines.
The characteristics of the programmed cell death induced by combined RNAi for c -raf and bcl -2
Apart from phosphatidylserine externalization on the outer membrane, the programmed cell death induced in the myeloid leukemia cell lines HL -60, U937, and THP -1 was characterized by the activation of caspase-3, one of the central executioner caspases. As shown in Figure 4 , the percentage of cells in which active caspase -3 could be detected significantly increased in the samples cotransfected with siRNA duplexes for c -raf and bcl -2 (23.1 ± 3.2% vs 3.2± 1.0% control, P < .05). About the same percentage of cells also expressed the conformational epitope of the cleaved fragment of PARP, one of the main substrates of caspase activity in the cells committed to programmed cell death (24.8± 3.3% vs 3.7 ± 1.2% control, P <.05 ).
The mitochondrial transmembrane potential ÁÉ m , as measured by the mitochondrial potentiometric marker DiOC uptake, showed a decrease in a significant percentage of cells cotransfected with siRNA duplexes for c -raf and bcl -2 ( 28.3 ± 4.0% vs 7.1 ± 1.1% control, P < .05), demonstrating the essential role played by the mitochondria in this process of programmed cell death induction.
Finally, the TdT-mediated nick -end labeling showed that the percentage of cells with an FITC -dUTP -labeled DNA as an indicator of endonuclease activity was significantly increased in the cells cotransfected with siRNA duplexes for c-raf and bcl -2 (30.2 ± 4.9% vs 2.6 ± 0.9% control, P < .05 ).
Combined RNAi for c -raf and bcl -2 induce a significant sensitization of HL -60, U937, and THP -1 cell lines to etoposide and daunorubicin
As both c -raf and bcl -2 genes were identified as playing important roles in the resistance to chemotherapy in leukemia, 17 -19 we next investigated if combined RNAi for c -raf and bcl -2 affected our leukemia cell lines' sensitivity to the programmed cell death -inducing drugs etoposide and daunorubicin. As shown in Figure 5 , cotransfection of HL -60, U937, and THP -1 cell lines with siRNA duplexes for c -raf and bcl -2 markedly increased apoptosis induction by etoposide, the percentage of cells entering programmed Figure 3 Programmed cell death induction by siRNA duplexes for c -raf and bcl -2. HL -60, U937, THP -1, and K562 cell lines were incubated for 96 hours with 800 nM siRNA duplexes for the c -raf gene and 800 nM siRNA duplexes for the bcl -2 gene, or with 400 nM siRNA duplexes for c -raf plus 400 nM siRNA duplexes for bcl -2 genes. After harvesting, the cells were stained with FITC -labeled Annexin V and 7 -AAD, and the percentage of apoptotic cells was quantified by flowcytometry. Shown are the mean ± SD of three independent experiments. Figure 2 RNAi for c -raf gene is able to block the surface CD14 expression induced by TPA. HL -60 cells were incubated for 3 days with 1 ng / mL TPA, with or without preincubation with siRNA duplexes for c -raf gene, then harvested, stained with PE -conjugated anti -CD14 mouse monoclonal antibody, and subjected to surface flowcytometric analysis. The percentage of cells displaying surface CD14 is depicted in each histogram. Gray -filled histograms represent surface CD14 expression, and dashed lines are the background fluorescence levels determined by staining with a corresponding PEconjugated isotype -matched control mouse monoclonal antibody. Representative for three separate experiments.
Cancer Gene Therapy RNA interference in myeloid leukemia DP Cioca et al cell death being shifted to etoposide concentrations one log rank lower (roughly 0.5 M etoposide plus 100 nM siRNA duplexes for c -raf and bcl -2 having the same effect as 5 M etoposide alone, and 5 M etoposide plus 100 nM siRNA duplexes for c-raf and bcl -2 being even more effective as 50 M etoposide alone ). This sensitization was specific for the combination of siRNA duplexes for c -raf and bcl -2 because neither 200 nM siRNA duplexes for the exogenous luciferase gene, nor 200 nM of each siRNA alone did increase the percentage of cells induced into programmed cell death by etoposide (data not shown).
Combined RNAi for c-raf and bcl -2 also sensitized HL -60, U937, and THP -1 cell lines to the programmed cell death induction by daunorubicin, as shown in Figure 6 . The effect of 0.1 M daunorubicin plus 100 nM siRNA duplexes for c -raf and bcl -2 genes was equivalent with that of 0.5 M daunorubicin alone, whereas cells treated with 0.5 M daunorubicin plus 100 nM siRNA duplexes for c-raf and bcl -2 displayed programmed cell death levels equivalent with that of 10 M daunorubicin. Figure 5 The sensitizing effect to etoposide of combined RNAi for c -raf and bcl -2. HL -60, U937, THP -1, and K562 cell lines were preincubated for 24 hours with ( A ) 200 nM siRNA duplexes for the exogenous luciferase gene ( control samples ) or with ( B ) 100 nM siRNA duplexes for c -raf plus 100 nM siRNA duplexes for bcl -2, followed by a 24 -hour exposure to different etoposide concentrations. After 24 hours, the cells were harvested and the percentage of apoptotic cells was flowcytometrically assayed by the fluorescent Annexin V method. Shown are the mean ± SD of three separate experiments. Figure 4 Characteristics of apoptosis induced by combined RNAi for c -raf and bcl -2. HL -60 cells were incubated with 800 nM siRNA duplexes for exogenous luciferase gene ( control samples ), or with 400 nM siRNA duplexes for c -raf plus 400 nM duplexes for bcl -2. After 96 hours, the cells were harvested and stained with PE -labeled anti -caspase -3 and FITC -labeled anti -PARP antibodies, or with the mitochondrial transmembrane potentiometric marker DiOC, or subjected to TUNEL assay. The subsequent flowcytometric analysis indicated the percentage of cells that display increased levels of active caspase -3, cleaved PARP, FITC -dUTP, or a reduced DiOC uptake. The background fluorescence levels using a corresponding PE -or FITC -labeled antibody are also shown ( dashed line histograms ). Representative of three independent experiments.
The drug sensitization effect of combined RNAi for c -raf and bcl -2 appeared at lower concentrations (100 nM ) than the siRNA concentrations required for spontaneous apoptosis augmentation ( 400 nM ), and after a shorter incubation period ( 24 hours ) than the period required to induce the spontaneous apoptotic response (96 hours ).
The K562 cell line, which does not express Bcl -2 and is particularly resistant to cell death by apoptosis irrespective of the inducing agent, 33, 34 was used as a negative control for the specific effects induced by siRNA duplexes for bcl -2. Indeed, as shown in Figures 3, 5 , and 6, cotransfection with siRNA duplexes for c-raf and bcl -2 did not induce programmed cell death in K562 cell line, nor did it sensitize these cells to apoptosis induced by etoposide and daunorubicin.
Discussion
The results presented in this study show that RNAi is a functional pathway with biological impact in myeloid leukemia cell lines and that this phenomenon has potential applicability as a therapeutic approach to myeloid leukemia. The RNAi using siRNA duplexes succeeded in significantly decreasing the endogenous levels of the target proteins, but not to create a complete knockdown phenotype by completely eliminating the c-raf and bcl -2 genes expression. Indeed, when compared with the RNAi results reported by Elbashir et al, 16 which succeeded in decreasing the expression of GL2 and GL3 firefly luciferases 3 -to 12 -fold and 9-to 25 -fold, respectively, our results of decreasing Raf -1 and Bcl -2 protein levels to 35% of their initial levels may seem modest. However, these reductions in Raf -1 and Bcl -2 endogenous levels were sufficient to trigger a significant augmentation of spontaneous apoptosis and to sensitize the HL -60, U937, and THP -1 cell lines to the apoptosis induction by etoposide and daunorubicin. Moreover, RNAi for c-raf succeeded in completely blocking the monocytic differentiation promoted by TPA in HL -60 cell line. Therefore, it is only reasonable to suppose that RNAi decreased the Raf -1 and Bcl -2 proteins to levels that were under a critical threshold and that the decreased protein levels failed to insure the critical endogenous levels required for monocytic differentiation and programmed cell death suppression. Longer incubation times may be necessary in order to insure a higher level of protein depletion, depending on the abundance or the reserves and the lifetime (or the turnover ) of the targeted protein.
Regarding Raf -1 kinase and Bcl -2 oncoprotein interaction, it was shown that Bcl -2 targets the protein kinase Raf -1 to mitochondria and that Raf -1 improves Bcl -2-mediated resistance to apoptosis, 35 a functional synergy existing between Bcl -2 and Raf -1 concerning suppression of apoptosis. 20 Our results show that only combined RNAi for c -raf and bcl -2 has a significant effect on programmed cell death induction and sensitization to the apoptosis induction by etoposide and daunorubicin, thus pointing to the existence of two independent pathways of cell survival controlled by Raf -1 and Bcl -2. Indeed, a report by Olivier et al 36 and a more recent one by Zhong et al 37 seem to confirm this hypothesis, by stating that Bcl -2 does not require Raf -1 kinase activity and that each protein by itself is sufficient to confer protection against programmed cell death.
It remains unexplained why in the case of K562 cell line, which is not expressing Bcl -2, RNAi using siRNA for c -raf or combined RNAi for c -raf and bcl -2 did not induce programmed cell death and did not sensitize the cell line to etoposide or daunorubicin. It was also demonstrated that in K562 cells, antisense oligonucleotides for c-raf -1 do not Figure 6 Combined RNAi for c -raf and bcl -2 and the daunorubicin sensitization. HL -60, U937, THP -1, and K562 cell lines were preincubated for 24 hours with ( A ) 200 nM siRNA duplexes for the exogenous luciferase gene ( control samples ) or with ( B ) 100 nM siRNA duplexes for c -raf plus 100 nM siRNA duplexes for bcl -2, followed by a 24 -hour exposure to different daunorubicin concentrations. The subsequent flowcytometric analysis quantified the percentage of apoptotic cells using the fluorescent Annexin V method. Shown are the mean ± SD of three separate experiments.
affect cell growth and do not increase sensitivity to etoposide, 17 similar with our results using siRNA for c -raf alone or in combination with siRNA for bcl -2. One possible explanation is that K562 relies on different pathways for survival and resistance to apoptosis. Indeed, it was shown that the K562 cell line does not express Bcl -2, but instead expresses high levels of the antiapoptotic protein Bcl -xL from the same family of apoptosis inhibitors. 31, 32 It is also possible that the Mcl -1 protein -belonging to the same Bcl -2 family of programmed cell death inhibitors and localized predominantly in the endoplasmic reticulum and nuclear envelope -having a cellular pattern of expression that overlaps with, but is not identical to, that of Bcl -2, 38 plays a significant role in the case of K562 line cells. Indeed, Mcl -1 was found to exert a function analogous to Bcl -2, targeting Raf -1 to mitochondria and reducing cell damageinduced release of mitochondrial cytochrome c -the increase in Mcl -1 proteins correlating with a reduced extent of apoptotic cell death induced by etoposide 39 and by fludarabine. 40 Further research is necessary to define the exact Bcl -2 -independent antiapoptotic mechanisms responsible for K562 cell line survival and protection from programmed cell death induction.
Raf -1 protein is a key regulator of mitogenic signals and the c-raf signaling pathway is activated in many human malignancies even in the absence of mutations. 41, 42 Therefore, a therapeutic approach using RNAi in order to decrease the endogenous levels of Raf -1 kinase is extremely attractive for many tumoral systems, where c-raf gene may play a crucial role in maintaining tumoral growth. However, Bcl -2 is also an attractive therapeutic target, being overexpressed in a wide variety of malignancies including acute myeloid leukemia, and its overexpression is often associated with clinical treatment failures and with regulation of clinical chemoresistance. 39, 40 Most intriguing, the temporary inhibition of Bcl -2 may not be toxic to normal cells, with Bcl -2 knockout mice surviving until birth with no histologic abnormalities. 43 Furthermore, inhibition of Bcl -2 does not automatically induce a compensatory up -regulation of other antiapoptotic proteins. 44 For all these reasons, our results regarding the significant biological effects of RNAi directed against the c -raf and bcl -2 genes should be considered as promising for a future RNAi-based therapeutic approach to myeloid leukemia or other malignancies, especially considering that RNAi has repeatedly proven itself to be more robust than antisense techniques because it works more often and typically decreases expression of a gene to lower levels, acting also at concentrations below that required for antisense experiments. 14, 16 In conclusion, the attempts described herein were directed to explore the functionality of the RNAi pathway in myeloid leukemia cells and to evaluate the biological significance of this phenomenon, suggesting the feasibility of myeloid leukemia cells' sensitization to chemotherapy by combined RNAi for c -raf and bcl -2 genes. Further research is necessary in order to improve the efficacy of the siRNA duplexes' delivery and action, to define the optimal therapeutic target genes, and to establish the conditions for in vivo and clinical applicability of RNAi.
